Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Ormco Corporation (Spark/Aligner Division) maintains a focused prosecution profile within the Biotechnology & Pharmaceuticals technology area. The company currently has 1 pending office action, which is assigned to 1 distinct examiner. This concentration suggests that the company's active intellectual property efforts are currently limited to a single technical inquiry. By operating within 1 distinct art unit, the company follows a specific set of examination guidelines tailored to its biotechnology innovations. This focused approach reduces the need to manage conflicting procedural requirements across different units.
The busiest examiner for Ormco Corporation (Spark/Aligner Division) is TSUI, YUNG-SHENG M, who is responsible for the 1 busiest examiner pending action. Because this examiner handles the only active matter in the portfolio, the company's immediate success at the USPTO depends on this individual's review. For a practitioner, this means that understanding the specific patterns and preferences of TSUI, YUNG-SHENG M is essential for the current portfolio. The alignment of 1 distinct examiner and 1 distinct art unit indicates a streamlined but highly centralized approach to patent acquisition. This centralization requires a highly tailored response to the specific examiner's feedback.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TSUI, YUNG-SHENG M | 1 | 66.5% | +6.3% |
| Art Unit | Apps |
|---|---|
| 1684 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18503562 | ORTHODONTIC APPLIANCES, SYSTEMS FOR MANUFACTURING ORTHODONTIC APPLIANCES, AND METHODS OF MANUFACTURING ORTHODONTIC APPLIANCES UTILIZING THOSE SYSTEMS | TSUI, YUNG-SHENG M | 1684 | §112 | Non-Final OA | — | Pending | Nov 07, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialOrmco Corporation (Spark/Aligner Division) has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Yung-Sheng M Tsui has the most, with 1 of Ormco Corporation (Spark/Aligner Division)'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
